Yuhan Corporation
Yuhan Corporation (KRX: 000100) is trading at ₩73,100.00, about ₹5,276 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 2.53% today. Yuhan is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩73,100.00
Today's high
₩74,700.00
52 week low
₩65,000.00
52 week high
₩129,200.00
000100 opened at ₩74,400.00, closed previously at ₩75,000.00, and has traded between ₩65,000.00 and ₩129,200.00 over the past 52 weeks.
About
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Key statistics
Avg. volume
283.30K
Market cap
₩5.38T
P/E Ratio
25.57
Price-to-sales ratio
2.36
Enterprise value
₩9.12T
Free cash flow yield
-0.04%
Debt-to-equity ratio
0.15
Return on equity
8.41%
ROIC
3.58%
Beta
0.41
Dividend yield
0.82%
Last dividend
₩600.00
Financial overview
Revenue
₩2.19T
Earnings per share
₩2,599.00
Free cash flow
-₩3.63B
Net profit margin
10.39%
Gross margin
34.30%
EBITDA
₩174.47B
Revenue growth
5.75%
Similar securities
This is not an investment recommendation
Yuhan for Indian investors
Yuhan is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Yuhan for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Yuhan’s current yield is 0.82%.Dividend tax explained
FAQs
Can I buy Yuhan on Paasa?
Yuhan (000100) has been listed on the Korea Exchange since 1962, in the Drug Manufacturers - Specialty & Generic industry. Yuhan is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Yuhan share cost in rupees?
One Yuhan share is ₩73,100.00 — about ₹5,276 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Yuhan price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Yuhan shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Yuhan price.
Does Yuhan pay a dividend, and how is it taxed in India?
Yes. Yuhan pays a dividend and the current yield is 0.82%; the last declared dividend was ₩600.00 per share, about ₹43.30. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Yuhan shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Yuhan?
Yes. Yuhan is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.